Catalyst
Slingshot members are tracking this event:
VIVUS Announces Intent to Reacquire U.S. and Canadian Rights for Stendra (Avanafil) from Endo
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 31, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Stendra, Commercial Rights, Rule 14e-2
